Evidence mapPaperPMID 40893482Full record

ReviewCurrent treatment options in cardiovascular medicine2025

Emerging Photoacoustic Imaging Techniques for Peripheral Arterial Disease.

Yide Zhang, Lihong V Wang

Abstract readReview
In one paragraph

Review in Current treatment options in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yide ZhangDepartment of Electrical, Computer, and Energy Engineering, University of Colorado Boulder, 425 UCB, 1111 Engineering Dr ECEE 1B55, Boulder, CO 80309 USA.
Lihong V WangCaltech Optical Imaging Laboratory, Andrew and Peggy Cherng Department of Medical Engineering, Department of Electrical Engineering, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125 USA.

Funding

The Center for Label-free Imagingand Multiscale Biophotonics (CLIMB)P41EB031772 · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · 2025 to 2025
$1.1M
Next-generation photoacoustic imaging for real-time, non-invasive monitoring of brain oxygen metabolismR00EB035645 · UNIVERSITY OF COLORADO · 2025 to 2025
$249k
NIBIB NIH HHS K99 EB035645NIBIB NIH HHS P41 EB031772NIBIB NIH HHS R00 EB035645
6 · The paper itself

Abstract

Purpose of Review: Photoacoustic imaging (PAI) has emerged as a promising non-ionizing modality that leverages optical absorption contrast to provide both anatomical and functional insights into vascular health. This review examines recent advances in PAI technologies applied to the diagnosis, assessment, and management of peripheral arterial disease (PAD). The goal is to evaluate how emerging PAI techniques address current diagnostic limitations and to identify opportunities for clinical integration. Recent Findings: Recent studies have demonstrated the potential of PAI to capture high-resolution, dynamic images of peripheral vasculature, quantify oxygen saturation and regional blood volume, and assess microvascular health. Technological innovations, including single-shot volumetric imaging, all-optical scanners, and multimodal systems, have expanded PAI's clinical utility. Summary: Emerging PAI systems show promise for complementing traditional imaging by providing functional insights into microvascular health. Continued technological development and validation through large-scale studies are essential for establishing PAI's clinical role in PAD diagnosis and management.

Indexed as

HemodynamicsMicrocirculationPeripheral arterial diseasePhotoacoustic imagingTranslational researchVascular imaging

Identifiers

PMID40893482
PMCPMC12394336

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.